4.4 Article

Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018

Journal

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume 41, Issue 4, Pages 2.09e13-2.09e22

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2023.01.024

Keywords

Renal cell carcinoma; Cardiovascular diseases; SEER data registry

Ask authors/readers for more resources

This study aimed to assess the frequency and risk of different causes of death in patients with renal cell carcinoma (RCC) in the United States. The majority of deaths were due to kidney cancer, but a significant proportion was caused by non-cancerous reasons. The proportion of deaths attributed to RCC decreased with increasing follow-up, and cardiovascular diseases and cerebrovascular diseases were the most common non-RCC-related causes of death. Coordination of multidisciplinary care is needed to prevent death from non-cancerous causes, depending on the stage of the disease.
Objectives: There has been little focus on the non-cancer causes of death in patients with renal cell carcinoma (RCC). Therefore, we aimed to assess the frequency and risk of different causes of death, stratified by tumor stage, and demographics, after a diagnosis of RCC in the United States.Materials and methods: Data on eligible patients with RCC from January 1, 2000, to December 31, 2018, in the United States were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Standardized mortality ratios for causes of death were calculated using the SEER*Stat software 8.3.9.2 for the overall population and stratified subgroups.Results: A total of 165,969 patients with RCC were included and 60,290 (36.3%) died during follow-up. The majority of deaths were due to kidney cancer (51.3%) but a significant proportion was non-cancer causes (37.6%). The proportion of deaths attributed to RCC decreased with increasing follow-up with non-cancer causes becoming dominant after the fifth year following RCC diagnosis. Overall, car-diovascular diseases and cerebrovascular diseases were the most common non-RCC-related causes of death. AJCC stage I and localized RCC had the most deaths attributed to non-cancerous causes (66.2% and 61.2%, respectively) while AJCC stage IV and distant RCC had the most deaths due to RCC (86.2% and 86.5%, respectively).Conclusion: A large proportion of RCC patients die of non-cancerous causes especially early-stage patients and advanced-stage patients who survive >5 years. Coordination of multidisciplinary care with relevant specialists depending on the stage of the disease is needed to better prevent death overtime from non-cancer causes. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available